Meeting | In Person
Event Title
Office of Minority Health and Health Equity Public Meeting on Strategies to Improve Health Equity Amidst the Opioid Crisis
November 21, 2019
The purpose of this meeting is to share information and obtain the public's perspectives on the current opioid crisis and how it affects minority populations.
- Organized By:
Event Recording and Slides:
_______________________________________________________________
The Food and Drug Administration is announcing the following public meeting entitled “Office of Minority Health and Health Equity Public Meeting on Strategies to Improve Health Equity Amidst the Opioid Crisis".
The purpose of this public meeting is to share information and obtain the public's perspectives on the current opioid crisis and how it specifically affects minority populations across the country, approaches to prevent and treat opioid use disorder, and emerging research as it relates to improving care for racial and ethnic minority, underrepresented, and underserved populations, and how FDA can support those efforts.
Thursday, November 21, 2019
9 am to 4 pm ET
Hilton Washington, DC/Rockville Hotel & Executive Meeting Center
1750 Rockville Pike
Roosevelt/Madison Rooms
Rockville, MD 20852
For Further Information Contact:
FDA Office of Minority Health and Health Equity
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
HealthEquity@fda.hhs.gov
Event Materials
| Title | File Type/Size |
|---|---|
| Opioids Meeting Presentation 2019 | pdf (105.68 MB) |
| Opioids Meeting Program 2019 | pdf (1.61 MB) |